U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07577466) titled 'Screening, Characterization, and Longitudinal Follow-up of Patients With Cardiac Amyloidosis' on May 04.
Brief Summary: Cardiac amyloidosis is a progressive disorder caused by extracellular deposition of amyloid fibrils in the heart, leading to heart failure and impaired cardiac function. Early diagnosis and targeted therapies are essential to improve patient outcomes. This prospective, single-center study aims to longitudinally follow patients with suspected cardiac amyloidosis to characterize disease progression and assess treatment effects. Participants will undergo cardiac magnetic resonance imaging (resting and exercise stress M...